The response assessment value of serum free light chain in the chemotherapy for IgG multiple myeloma

Hai-fei CHEN,Jian HOU,Dong-xing WANG,Wei-jun FU,Zhen-gang YUAN,Yu-bao CHEN,Chun-yang ZHANG

DOI: https://doi.org/10.3969/j.issn.1007-3639.2007.08.009

2007-01-01

Abstract:Background and purpose:Monoclonal immunoglobulin free light chains (FLC) are found in the serum and urine of patients with a number of B-cell proliferative disorders, including multiple myeloma(MM). The quantitative assay for serum free light chains (sFLC) was recently introduced and the commercial test has been proved to be sensitive and specific for detecting plasma cell dyscrasia. Our aim was to explore the clinical significance of sFLC measurement in IgG multiple myeloma(MM). Methods:sFLC and IgG were measured in 30 patients with IgG MM at days 7-10(early stage) and days 28-35(late stage) after the first cycle of chemotherapy by nephelometry. Patient's responses were assessed according to levels of sFLC and IgG at early and late stage, and twenty one patients who had measurable disease were followed up after the second cycle of chemotherapy.Results:Twenty three out of the 30 patients had abnormal elevated sFLC and abnormal ratio of free κ/λ. Twenty one patients had abnormal total light chain levels and abnormal κ/λ ratio. Both of sFLC and total light chain were abnormal in five newly diagnosed MM patients and 6 patients with progressive diseases. The pearson correlation coefficient between sFLC and total light chain levels was 0.64 at baseline. The sensibility and specificity of response of PR (partial remission) were 100% and 92.3% according to the sFLC assessment criteria at the early stage while the sensibility of response of PR was 25% according to the IgG assessment criteria. The sensibility and specificity of response of PD were 100% and 93.8% according to the sFLC criteria at the late stage meanwhile the sensibility of response of PD according to IgG criteria were zero.Conclusions:More than 75% of patients with IgG MM had abnormal sFLC concentrations and abnormalκ/λ ratio. Serum FLC concentration responded more quickly to treatment than IgG and provided early evidence of progressive disease.